Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)

Market Cap	12.10B
Revenue (ttm)	1.39B
Net Income (ttm)	410.59M
Shares Out	70.00M
EPS (ttm)	5.86
PE Ratio	29.47
Forward PE	28.51
Dividend	3.06 (1.77%)
Ex-Dividend Date	Mar 5, 2025

Volume	52,092
Average Volume	99,785
Open	173.20
Previous Close	173.00
Day's Range	170.80 - 175.40
52-Week Range	128.20 - 202.40
Beta	n/a
RSI	66.33
Earnings Date	Apr 27, 2025

About TADAWUL:4015

Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdo...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Country: Saudi Arabia
• Stock Exchange: Saudi Stock Exchange
• Ticker Symbol: 4015

Financial Performance

In 2024, TADAWUL:4015's revenue was 1.32 billion, an increase of 19.77% compared to the previous year's 1.10 billion. Earnings were 356.52 million, an increase of 21.93%.